ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 662,53
0,27%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Vaccinex Inc (VCNX)

  7. Vaccinex Inc (VCNX) Actualités

VCNX

Vaccinex (VCNX)

Vaccinex Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VCNX
DateHeureSourceTitreSymboleSociété
31/05/202422h31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCNXVaccinex Inc
16/05/202400h00GlobeNewswire Inc.Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
15/05/202423h24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCNXVaccinex Inc
14/05/202422h36Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:VCNXVaccinex Inc
13/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VCNXVaccinex Inc
10/05/202418h33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCNXVaccinex Inc
09/05/202423h08Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VCNXVaccinex Inc
09/05/202422h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCNXVaccinex Inc
08/05/202418h29Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:VCNXVaccinex Inc
02/04/202414h30GlobeNewswire Inc.Vaccinex Reports 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
27/03/202413h30GlobeNewswire Inc.Vaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:VCNXVaccinex Inc
21/02/202414h00GlobeNewswire Inc.Vaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyNASDAQ:VCNXVaccinex Inc
15/02/202414h00GlobeNewswire Inc.Vaccinex, Inc. Announces Reverse Stock SplitNASDAQ:VCNXVaccinex Inc
13/02/202422h15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:VCNXVaccinex Inc
09/02/202422h08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VCNXVaccinex Inc
08/02/202414h20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:VCNXVaccinex Inc
07/02/202414h00GlobeNewswire Inc.Vaccinex Announces Pricing of $3.7 Million PIPE FinancingNASDAQ:VCNXVaccinex Inc
10/01/202423h16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VCNXVaccinex Inc
08/01/202422h16Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VCNXVaccinex Inc
28/12/202322h15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VCNXVaccinex Inc
04/12/202314h00GlobeNewswire Inc.Nasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing RuleNASDAQ:VCNXVaccinex Inc
13/11/202314h00GlobeNewswire Inc.Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:VCNXVaccinex Inc
31/10/202314h00GlobeNewswire Inc.Vaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual MeetingNASDAQ:VCNXVaccinex Inc
26/10/202315h30GlobeNewswire Inc.Vaccinex Reports Positive Effect of Pepinemab Treatment on New Biomarker of Brain Inflammation in Neurodegenerative DiseasesNASDAQ:VCNXVaccinex Inc
02/10/202315h16Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:VCNXVaccinex Inc
29/09/202302h41Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:VCNXVaccinex Inc
26/09/202314h01Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VCNXVaccinex Inc
14/09/202323h26Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VCNXVaccinex Inc
25/05/202322h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:VCNXVaccinex Inc
19/05/202323h15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VCNXVaccinex Inc
 Showing the most relevant articles for your search:NASDAQ:VCNX

Dernières Valeurs Consultées

ASX
NNG
Nexion
TG
4CU
Centrus Energy
COIN
OLEAUST
Olea Token
TG
LACB
Sterling Metals
COIN
ADVBUST
Adverb
TSXV
URC
Uranium Royalty
LSE
DO1C
Comw.bk.a.31
TG
931
Sea
COIN
NSBTGBP
Neutrino System Base Token
TG
XEB
Sojitz
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés